Patent · US Active

Cell scaffold matrices with incorporated therapeutic agents

US7531503B2 · kind B2 · utility

55Cited by

1References

16Claims

0Family size

Assignee

Wake Forest University Health Sciences · US

Inventors

Anthony Atala · Winston-Salem, US
James J. Yoo · Winston-Salem, US
Grace Lim · Winston-Salem, US
Richard Czerw · Clemmons, US
Shay Soker · Winston-Salem, US
Joel Stitzel · Winston-Salem, US

Key dates

Filing date	Mar 18, 2005
Grant date	May 12, 2009
Priority date	—
Expiry date	Nov 16, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/906
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to methods and compositions for preparing matrices for controlled delivery of at least one therapeutic or biological agent to a target site in a subject. This is accomplished using nanoparticles coupled to the therapeutic or biological agent that are incorporated within the matrix or reacted on the surface of the matrix.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.